Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Baculoviral IAP repeat-containing protein 2 (BIRC2), also known as cIAP1, is a multifunctional protein that regulates apoptosis, inflammation, immunity, and cell signaling pathways. It inhibits apoptosis by interfering with caspase activation and functions as an E3 ubiquitin-protein ligase. It is implicated in cancer and autoimmune/inflammatory diseases, making it a potential therapeutic target.
Inhibition of caspase activation, E3 ubiquitin ligase activity, regulation of inflammatory signaling.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Baculoviral IAP Repeat-Containing Protein 2 (cIAP1).